Amarin CORP Plcuk Form 4 insider transactions

Director Patrice Eadon Bonfiglio reports acquisition and disposal of Amarin shares related to restricted stock unit vesting and tax withholding.

Director Mark DiPaolo reports acquisition and disposal of Amarin shares related to vesting of restricted stock units and tax withholding, following an adjustment to the American Depositary Share (ADS) ratio.

Peter Fishman, CFO of Amarin, reports transactions involving ordinary shares and restricted stock units (RSUs) related to vesting and tax liabilities.

Amarin's Chief Scientific Officer, Steven B. Ketchum, reported multiple transactions involving the acquisition and disposal of ordinary shares following the vesting of restricted stock units (RSUs).

Amarin Corporation's CEO, Aaron Berg, acquired a significant number of ordinary shares through the vesting of restricted stock units (RSUs) on January 30th and 31st, 2025.

Amarin's CFO, Peter Fishman, reported the vesting of restricted stock units (RSUs) and associated tax withholdings, resulting in changes to his beneficial ownership of ordinary shares.

Amarin's Senior Vice President and CFO, Peter L. Fishman, was granted stock options for 440,475 ordinary shares on January 10, 2025.

Jonathan Provoost, EVP and Chief Legal Officer at Amarin, was granted stock options for 663,878 ordinary shares on January 10, 2025.

Amarin Corp's Chief Scientific Officer, Steven B. Ketchum, was granted stock options for 663,878 ordinary shares on January 10, 2025.

Amarin Corporation's CEO, Aaron Berg, recently purchased 160,000 ordinary shares at an average price of $0.64 per share.

Steven B. Ketchum, Chief Scientific Officer of Amarin Corp PLC, reports acquisition and disposal of ordinary shares related to restricted stock units.

Amarin Corporation's CEO, Aaron Berg, reports the vesting of restricted stock units and the grant of a new stock option.

Thomas Reilly, EVP and CFO of Amarin, reports acquisition and disposal of ordinary shares and restricted stock units.

EVP and CFO of Amarin Corp PLC, Thomas Reilly, reports the vesting of restricted stock units and subsequent tax withholding.

Director Paul Cohen received stock options for 179,795 ordinary shares and 50,287 restricted stock units (RSUs) following Amarin's annual general meeting.

Director Diane E. Sullivan was granted stock options and restricted stock units (RSUs) following Amarin's annual general meeting.

Director Louis Sterling III was granted stock options and restricted stock units (RSUs) following Amarin's annual general meeting.

Director Oliver O'Connor received stock options and restricted stock units (RSUs) from Amarin Pharma following the company's annual general meeting.

Director Kostas D. Odysseas receives stock options and restricted stock units (RSUs) following Amarin's annual general meeting.

Director Keith Horn received stock options for 179,795 ordinary shares and 50,287 restricted stock units (RSUs) following Amarin's annual general meeting.

Mark DiPaolo, a director of Amarin Corp PLC, was granted stock options and restricted stock units (RSUs) following the company's annual general meeting.

Director Patrice Eadon Bonfiglio acquired stock options and restricted stock units (RSUs) following Amarin's annual general meeting.